 Regular beta-agonist treatment bronchial asthma subjects stable asthma part double-blind placebo-controlled crossover study effects regular versus on-demand inhaled bronchodilator therapy subjects fenoterol placebo dry powder delivery system weeks Control asthma daily morning evening peak expiratory flow rates symptom diaries use additional inhaled bronchodilator requirement short courses prednisone subjects trial clear difference degree control asthma fenoterol placebo periods confidence interval asthma regular inhaled bronchodilator treatment whereas control placebo treatment bronchodilator symptom relief Mean responsiveness fenoterol period adverse effect regular bronchodilator inhalation subjects bronchodilator sole treatment regular bronchodilator treatment inhaled corticosteroids regular inhalation beta-sympathomimetic agent deterioration asthma control majority subjects trends regular doses longer-acting inhaled beta-sympathomimetic treatment important causal factor worldwide increase morbidity asthma